Betahistine Therapy
Betahistine Therapy is a pharmacological treatment modality that specifically involves the administration of betahistine dihydrochloride to alleviate vestibular symptoms in Ménière’s disease by purportedly enhancing inner ear microcirculation and reducing endolymphatic hydrops.
140
Publications
4.8K
Citations
490
Authors
230
Institutions
Publications per year
2017–2026
26
Parents
140
Christine Adrion, Carolin Fischer, Judith Wagner et al. · BMJ · 2016 · 201 citations · Full text
Medicine, Neurology, Pharmacology +13
1–5 of 140
490
9
h-index
6
h-index
6
h-index
6
h-index
5
h-index
1–5 of 490
230

University of Wollongong
Wollongong, Australia
7 h-index
24 publications
1.2K citations
Illawarra Health and Medical Research Institute
Keiraville, Australia
7 h-index
20 publications
979 citations
University of Pavia
Pavia, Italy
7 h-index
15 publications
449 citations
Schizophrenia Research Institute
Sydney, Australia
5 h-index
10 publications
506 citations
München Klinik
Munich, Germany
4 h-index
7 publications
811 citations
University of Siena
Siena, Italy
4 h-index
7 publications
307 citations

University of Göttingen
Göttingen, Germany
4 h-index
13 publications
437 citations
Laboratoire de Neurosciences Intégratives et Adaptatives
Marseille, France
4 h-index
11 publications
760 citations
1–8 of 230
16 publications · 506 citations
14
h-index
Repository · 19 publications · 437 citations
12
h-index
7 publications · 321 citations
7
h-index
6 publications · 341 citations
6
h-index
4 publications · 80 citations
4
h-index
1–5